# Azilect + Antidepressant Chart Review

> **NCT00955604** · — · COMPLETED · sponsor: **Teva Branded Pharmaceutical Products R&D, Inc.** · enrollment: 1500 (estimated)

## Conditions studied

- Serotonin Syndrome

## Interventions

- **DRUG:** Group R+AD Rasagiline + Antidepressant
- **DRUG:** Group R Rasagiline
- **DRUG:** Group AD Anti-PD + Antidepressant

## Key facts

- **NCT ID:** NCT00955604
- **Lead sponsor:** Teva Branded Pharmaceutical Products R&D, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-03
- **Final completion:** 2010-06
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2017-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00955604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00955604, "Azilect + Antidepressant Chart Review". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00955604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*